Eli Lilly's long-term growth prospects are strong with improved supply, new growth opportunities, and competitive positioning ...

In a report released yesterday, Alec Stranahan from Bank of America Securities maintained a Buy rating on Eli Lilly & Co (LLY – ...

Although Lilly started consistently raising its dividend in 2015, investors should be aware of some details around the schedule of these payments. Every year since then, Lilly announced a hike to its ...

We recently compiled a list of the 10 Best Counter Cyclical and Defensive Stocks to Invest In. In this article, we are going ...

Eli Lilly and Company has announced the FDA approval of EBGLYSS for treating atopic dermatitis in adults and children over 12 ...

Since the start of 2020, Eli Lilly ... company, Genetic Leap. The partnership centers on developing new drugs, particularly those targeting RNA, which attempt to treat diseases at their genetic ...

Eli Lilly and Company has revealed positive topline results from the Phase III trials of efsitora alfa to treat adults with ...

In this article, we will have a look at where Eli Lilly and Company (NYSE ... these stocks still have plenty of room to grow. Their rising significance is tied to the fact that US companies ...

Eli Lilly and Company’s LLY stock has risen 21.1% in six months compared with an increase of 10.5% for the industry. The stock has also outperformed the sector as well as the S&P 500 as seen in ...

Eli Lilly & Co. (NYSE:LLY) reported much stronger-than-expected earnings for the fiscal Q2 2024 and raised its guidance for the full year. The drugmaker’s shares surged more than ...

BMO Capital Markets increased their price target on shares ... Receive News & Ratings for Eli Lilly and Company Daily - Enter your email address below to receive a concise daily summary of the ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 607.25% and currently trading at $935.06.The company has been around since 1876 and ...